Cerebral hemodynamics and vascular risk factors: Setting the stage for Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 32, Issue 3, 2012, Pages 553-567

  De La Torre, Jack C ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Alzheimer's disease; atherosclerosis; brain hypoperfusion; cerebral blood flow; cerebral hemodynamics; cognition; diabetes; hypertension; Poiseuille's law; vascular risk factors

Indexed keywords

AMYLOID BETA PROTEIN; TAU PROTEIN;

ALZHEIMER DISEASE; ASTROCYTE; ATHEROSCLEROSIS; BRAIN ARTERY; BRAIN ATROPHY; BRAIN BLOOD FLOW; BRAIN PERFUSION; COGNITION; DISEASE SEVERITY; ENDOTHELIUM CELL; ENERGY; GERIATRIC PATIENT; HEMODYNAMIC PARAMETERS; HUMAN; HYPERTENSION; INTIMA MEDIA STENOSIS; LETHALITY; NERVE CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUTRIENT; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; REVIEW; RISK ASSESSMENT; SIGNAL TRANSDUCTION; STENOSIS; VASCULAR DISEASE; VASCULAR RESISTANCE; VASCULAR SMOOTH MUSCLE;

EID: 84871390978     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2012-120793     Document Type: Review

References (162)

1. Roy CS, Sherrington CS (1890) On the regulation of the blood-Supply of the brain. J Physiol 11, 85-108.
2. Berne RM, Winn HR, Rubio R (1981) The local regulation of cerebral blood flow. Prog Cardiovasc Dis 24, 243-260.
3. Cipolla MJ (2009) The Cerebral Circulation. Morgan & Claypool Publishers, San Rafael, C.A.
4. Attwell D, Buchan AM, Charpak S, Lauritzen M, Macvicar BA, Newman EA (2010) Glial and neuronal control of brain blood flow. Nature 468, 232-243.
5. Paulson OB, Hasselbalch SG, Rostrup E, Knudsen GM, Pelligrino D (2010) Cerebral blood flow response to functional activation. J Cereb Blood Flow Metab 30, 2-14.
6. de la Torre JC, Mussivand T (1993) Can disturbed brain microcirculation cause alzheimer's disease? Neurol Res 15, 146-153. (Pubitemid 23166998)
7. Iadecola C (2004) Neurovascular regulation in the normal brain and in alzheimer's disease. Nat Rev Neurosci 5, 347-360. (Pubitemid 38568496)
8. Pfitzner J (1976) Poiseuille and his law. Anaesthesia 31, 273-275.
9. Pollock SS, Harrison MJ (1982) Red cell deformability is not an independent risk factor for stroke. J Neurol Neurosurg Psychiatry 45, 369-371. (Pubitemid 12150156)
10. Kim S, Ong P, Yalcin O, Intaglietta M, Johnson PC (2009) The cell-free layer in microvascular blood flow. Biorheology 46, 181-189.
11. Fung YYC (1981) Biomechanics, Springer-Verlag, New York
12. Nair PK, Hellums J, Olson J (1989) Prediction of oxygen transport rates in blood flowing in large capillaries. Microvasc Res 36, 269-285. (Pubitemid 20025050)
13. Nguyen J, Nishimura N, Fetcho RN, Iadecola C, Schaffer CB (2011) Occlusion of cortical ascending venules causes blood flow decreases, reversals in flow direction, and vessel dilation in upstream capillaries. J Cereb Blood Flow Metab 31, 2243-2254.
14. LoGerfoFW, CrawshawHM, NowakM, Serrallach E, Quist WC, Valeri CR (1981) Effect of flow split on separation and stagnation in a model vascular bifurcation. Stroke 12, 660-665. (Pubitemid 11030074)
15. Provinciali L, Minciotti P, Ceravolo MG, Chiaramoni L, Maricotti M, Mauro A, Salvolini U (1992) Haemodynamic changes following carotid occlusion: MRI angiography and transcranial Doppler patterns. Neurol Res 14(2 Suppl), 208-210.
16. De Keulenaer GW, Chappell DC, Ishizaka N, Nerem RM, Alexander RW, Griendling KK (1998) Oscillatory and steady laminar shear stress differentially affect human endothelial redox-State: Role of a superoxide-producing NADH oxidase. Circ Res 82, 1094-1101. (Pubitemid 28249070)
17. Busse R, Fleming I (1998) Pulsatile stretch and shear stress; physical stimuli determining the production of endotheliumderived relaxing factors. J Vasc Res 35, 73-84. (Pubitemid 28191773)
18. Heo KS, Fujiwara K, Abe J (2011) Disturbed-flow-mediated vascular reactive oxygen species induce endothelial dysfunction. Circ J 75, 2722-2730.
19. de laTorre JC, StefanoGB(2000) Evidence that alzheimer's disease is a microvascular disorder: The role of constitutive nitric oxide. Brain Res Brain Res Rev 34, 119-136.
20. Stuart J, Nash GB (1990) Red cell deformability and haematological disorders. Blood Rev 4, 141-147. (Pubitemid 20302044)
21. Bayliss WM (1902) On the local reactions of the arterial wall to changes of internal pressure. J Physiol 28, 220-231.
22. Leenders KL, Perani D, Lammertsma AA, Heather JD, Buckingham P, Healy MJ, Gibbs JM, Wise RJ, Hatazawa J, Herold S (1990) Cerebral blood flow, blood volume and oxygen utilization. Normal values and effect of age. Brain 113(Pt 1), 27-47. (Pubitemid 20047108)
23. Chen Y, Wolk DA, Reddin JS, Korczykowski M, Martinez PM, Musiek ES, Newberg AB, Julin P, Arnold SE, Greenberg JH, Detre JA (2011) Voxel-Level comparison of arterial spin-Labeled perfusion MRI and FDG-PET in alzheimer disease. Neurology 77, 1977-1985.
24. Zou Q, Wu CW, Stein EA, Zang Y, Yang Y (2009) Static and dynamic characteristics of cerebral blood flow during the resting state. Neuroimage 48, 515-524.
25. HeissWD(2000) Ischemic penumbra: Evidence from functional imaging in man. J Cereb Blood Flow Metab 20, 1276-1293.
26. Alavi A, Newberg AB, Souder E, Berlin JA (1993) Quantitative analysis of PET and MRI data in normal aging and alzheimer's disease: Atrophy weighted total brain metabolism and absolute whole brain metabolism as reliable discriminators. J Nucl Med 34, 1681-1687. (Pubitemid 23295377)
27. Tohgi H, Yonezawa H, Takahashi S, Sato N, Kato E, Kudo M, Hatano K, Sasaki T (1998) Cerebral blood flow and oxygen metabolism in senile dementia of alzheimer's type and vascular dementia with deep white matter changes. Neuroradiology 40, 131-137. (Pubitemid 28438820)
28. Tonini G, Shanks MF, Venneri A (2003) Short-Term longitudinal evaluation of cerebral blood flow in mild alzheimer's disease. Neurol Sci 24, 24-30. (Pubitemid 36621526)
29. Mosconi L, Mistur R, Switalski R, Tsui WH, Glodzik L, Li Y, Pirraglia E, De Santi S, Reisberg B, Wisniewski T, de Leon MJ (2009) FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified alzheimer's disease. Eur J Nucl Med Mol Imaging 36, 811-822.
30. Aizenstein HJ, Nebes RD, Saxton JA, Price JC, Mathis CA, Tsopelas ND (2008) Frequent amyloid deposition without significant cognitive impairment among the elderly. Arch Neurol 65, 1509-1517.
31. Huang C, Wahlund LO, Svensson L, Winblad B, Julin P (2002) Cingulate cortex hypoperfusion predicts alzheimer's disease in mild cognitive impairment. BMC Neurol 2, 9-16.
32. Chetelat G, Desgranges B, de la Sayette V, Viader F, Eustache F, Baron JC (2003) Mild cognitive impairment Can FDG-PET predict who is to rapidly convert to alzheimer's disease? Neurology 60, 1374-1377. (Pubitemid 36461002)
33. Hansson O, Buchhave P, ZetterbergH, BlennowK,Minthon L, Warkentin S (2009) Combined rCBF and CSF biomarkers predict progression from mild cognitive impairment to alzheimer's disease. Neurobiol Aging 30, 165-173.
34. Matsuda H (2007) The role of neuroimaging in mild cognitive impairment. Neuropathology 27, 570-577. (Pubitemid 350045667)
35. Alsop DC, Dai W, Grossman M, Detre JA (2010) Arterial spin labeling blood flow MRI: Its role in the early characterization of alzheimer's disease. J Alzheimers Dis 20, 871-880.
36. de la Torre JC (2000) Critically attained threshold of cerebral hypoperfusion: The CATCH hypothesis of alzheimer's pathogenesis. Neurobiol Aging 21, 331-342. (Pubitemid 30387092)
37. Sun X, He G, Qing H, Zhou W, Dobie F, Cai F, Staufenbiel M, Huang LE, Song W (2006) Hypoxia facilitates alzheimer's disease pathogenesis by up-Regulating BACE1 gene expression. Proc Natl Acad Sci U S A 103, 18727-18732. (Pubitemid 44913478)
38. Velliquette RA, O'Connor T, Vassar R (2005) Energy inhibition elevates beta-Secretase levels and activity and is potentially amyloidogenic in APP transgenic mice: Possible early events in alzheimer's disease pathogenesis. J Neurosci 25, 10874-10883. (Pubitemid 41692617)
39. Koike MA, Green KN, Blurton-Jones M, Laferla FM (2010) Oligemic hypoperfusion differentially affects tau and amyloid-{beta}. Am J Pathol 177, 300-310.
40. Liu D, Pitta M, Lee JH, Ray B, Lahiri DK, Furukawa K, Mughal M, Jiang H, Villarreal J, Cutler RG, Greig NH, Mattson MP (2010) The KATP channel activator diazoxide ameliorates amyloid- And tau pathologies and improves memory in the 3xTg AD mouse model of alzheimer's disease. J Alzheimers Dis 22, 443-457.
41. Kennedy AM, Frackowiak RS, Newman SK, Bloomfield PM, Seaward J, Roques P, Lewington G, Cunningham VJ, Rossor MN (1995) Deficits in cerebral glucose metabolism demonstrated by positron emission tomography in individuals at risk of familial alzheimer's disease. Neurosci Lett 186, 17-20.
42. Kogure D, Matsuda H, Ohnishi T, Asada T, Uno M,Kunihiro T, Nakano S, TakasakiM(2000) Longitudinal evaluation of early alzheimer's disease using brain perfusion SPECT. J Nucl Med 41, 1155-1162. (Pubitemid 30463997)
43. Caroli A, Testa C, Geroldi C, Nobili F, Barnden LR, Guerra UP, Bonetti M, Frisoni GB (2007) Cerebral perfusion correlates of conversion to alzheimer's disease in amnestic mild cognitive impairment. J Neurol 254, 1698-1707.
44. Ruitenberg A, den Heijer T, Bakker SL, van Swieten JC, Koudstaal PJ, Hofman A, Breteler MM (2005) Cerebral hypoperfusion and clinical onset of dementia: The rotterdam study. Ann Neurol 57, 789-794. (Pubitemid 40798616)
45. Toda N (2012) Age-Related changes in endothelial function and blood flow regulation. Pharmacol Ther 133, 159-176.
46. Devanand DP, Habeck CG, Tabert MH, Scarmeas N, Pelton GH, Moeller JR, Mensh BD, Tarabula T, Van Heertum RL, Stern Y (2006) PET network abnormalities and cognitive decline in patients with mild cognitive impairment. Neuropsychopharmacology 31, 1327-1334. (Pubitemid 43971849)
47. Johnson NA, Jahng GH, Weiner MW, Miller BL, Chui HC, Jagust WJ, Gorno-Tempini ML, Schuff N (2005) Pattern of cerebral hypoperfusion in alzheimer disease and mild cognitive impairment measured with arterial spin-Labeling MR imaging: Initial experience. Radiology 234, 851-859. (Pubitemid 40250829)
48. Edman A, Edenbrandt L, Fred'en-Lindqvist J, Nilsson M, Wallin A (2011) Asymmetric cerebral blood flow in patients with mild cognitive impairment: Possible relationship to further cognitive deterioration. Dement Geriatr Cogn Dis Extra 1, 228-236.
49. Josephs KA, Whitwell JL, Ahmed Z, Shiung MM,Weigand SD, Knopman DS, Boeve BF, Parisi JE, Petersen RC, Dickson DW, Jack CR Jr (2008) Beta-Amyloid burden is not associated with rates of brain atrophy. Ann Neurol 63, 204-212. (Pubitemid 351355299)
50. Carlson BE, Arciero JC, Secomb TW (2008) Theoretical model of blood flow autoregulation: Roles of myogenic, shear-Dependent, and metabolic responses. Am J Physiol Heart Circ Physiol 295, H1572-H1579.
51. Dirnagl U, Niwa K, Lindauer U, Villringer A (1994) Coupling of cerebral blood flow to neuronal activation: Role of adenosine and nitric oxide. Am J Physiol Heart Circ Physiol 267, H296-H301.
52. Mulligan SJ, MacVicar BA (2004) Calcium transients in astrocyte endfeet cause cerebrovascular constrictions. Nature 431, 195-199. (Pubitemid 39243473)
53. Cipolla MJ (2009) The Cerebral Circulation. Morgan & Claypool Life Sciences, San Rafael, C.A.
54. Johnson PC (1981) The myogenic response. In Handbook of Physiology The Cardiovascular System. Vascular Smooth Muscle, Section 2, Vol. II. American Physiological Society, Bethesda, MD, pp 409-442.
55. Faraci FM, Heistad DD (1998) Regulation of the cerebral circulation: Role of endothelium and potassium channels. Physiol Rev 78, 53-97. (Pubitemid 28070975)
56. Oberheim NA, Wang X, Goldman S, Nedergaard M (2006) Astrocytic complexity distinguishes the human brain. Trends Neurosci 29, 547-553. (Pubitemid 44416461)
57. Simard M, Arcuino G, Takano T, Liu QS, Nedergaard M (2003) Signaling at the gliovascular interface. J Neurosci 23, 9254-9262. (Pubitemid 37243827)
58. Carmignoto G, G'omez-GonzaloM(2010) The contribution of astrocyte signalling to neurovascular coupling. Brain Res Brain Res Rev 63, 138-148.
59. Takano T, Tian GF, Peng W, Lou N, Libionka W (2006) Astrocyte-mediated control of cerebral blood flow. Nat Neurosci 9, 260-267. (Pubitemid 43164550)
60. Araque A, Parpura V, Sanzgiri RP, Haydon PG (1999) Tripartite synapses: Glia, the unacknowledged partner. Trends Neurosci 22, 208-215. (Pubitemid 29202082)
61. Perea G, Navarrete M, Araque A (2009) Tripartite synapses: Astrocytes process and control synaptic information. Trends Neurosci 32, 421-431.
62. Cornell-Bell AH, Finkbeiner SM, Cooper MS, Smith SJ (1990) Glutamate induces calcium waves in cultured astrocytes: Long-Range glial signaling. Science 247, 470-473.
63. Peterson EC,Wang Z, Britz G (2011) Regulation of cerebral blood flow. Int J Vasc Med 2011, 823525.
64. Harder DR (1987) Pressure-induced myogenic activation of cat cerebral arteries is dependent on intact endothelium. Circ Res 60, 102-107. (Pubitemid 17056935)
65. Jackson PA, Duling BR (1989) Myogenic response and wall mechanics of arterioles. Am J Physiol 257(4 Pt 2), H1147-H1155.
66. Andresen J, Shafi NI, BryanRMJr (2006) Endothelial influences on cerebrovascular tone. J Appl Physiol 100, 318-327. (Pubitemid 43671124)
67. Abbott NJ, Rönnbäck L, Hansson E (2006) Astrocyteendothelial interactions at the blood-Brain barrier. Nat Rev Neurosci 7, 41-53.
68. Zonta M, Angulo MC, Gobbo S, Rosengarten B, Hossmann KA, Pozzan T (2003) Neuron-To-Astrocyte signaling is central to the dynamic control of brain microcirculation. Nat Neurosci 6, 43-50. (Pubitemid 36026331)
69. Straub SV, Bonev AD, Wilkerson MK, Nelson MT (2006) Dynamic inositol trisphosphate-mediated calcium signals within astrocytic endfeet underlie vasodilation of cerebral arterioles. J Gen Physiol 128, 659-669. (Pubitemid 44833378)
70. Harder DR (1984) Pressure-Dependent membrane depolarization in cat middle cerebral artery. Circ Res 55, 197-202. (Pubitemid 14032935)
71. Koehler RC, Gebremedhin D, Harder DR (2006) Role of astrocytes in cerebrovascular regulation. J Appl Physiol 100, 307-317. (Pubitemid 43671123)
72. Filosa JA, BlancoVM(2007) Neurovascular coupling in the mammalian brain. Exp Physiol 92, 641-646. (Pubitemid 47024943)
73. Gordon GR, Howarth C, MacVicar BA (2011) Bidirectional control of arteriole diameter by astrocytes. Exp Physiol 96, 393-399.
74. Gebremedhin D, Lange AR, Narayanan J, AeblyMR,Jacobs ER, Harder DR (1998) Cat cerebral arterial smooth muscle cells express cytochrome P450 4A2 enzyme and produce the vasoconstrictor 20-HETE which enhances L-Type Ca2+ current. J Physiol 507(Part 3), 771-781. (Pubitemid 28143578)
75. Koehler RC, Roman RJ, Harder DR (2009) Astrocytes and the regulation of cerebral blood flow. Trends Neurosci 32, 160-169.
76. NelsonMT, QuayleJM(1995) Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol 268(4 Pt 1), C799-C822.
77. Kitazono T, Faraci FM, Taguchi H, Heistad DD (1995) Role of potassium channels in cerebral blood vessels. Stroke 26, 1713-1723.
78. Taguchi H, Heistad DD, Kitazono T, Faraci FM (1994) ATP-Sensitive K+ channels mediate dilatation of cerebral arterioles during hypoxia. Circ Res 74, 1005-1008. (Pubitemid 24121605)
79. Baron JC, Bousser MG, Rey A, Guillard A, Comar D, Castaigne P (1981) Reversal of focal "misery-perfusion syndrome" by extra-intracranial arterial bypass in hemodynamic cerebral ischemia A case study with 15O positron emission tomography. Stroke 12, 454-459. (Pubitemid 11046690)
80. Heistad DD (2001) What's new in the cerebral microcirculation? Landis Award lecture. Microcirculation 8, 365-375.
81. Suzuki N, Hardebo JE (1993) The cerebrovascular parasympathetic innervation. Cerebrovasc Brain Metab Rev Spring 5, 33-46.
82. Hamilton NB, Attwell D, HallCN(2010) Pericyte-mediated regulation of capillary diameter: A component of neurovascular coupling in health and disease. Front Neuroenergetics 2, pii: 5.
83. de la Torre JC (1997) Hemodynamic consequences of deformed microvessels in the brain in alzheimer's disease. Ann N Y Acad Sci 826, 75-91.
84. Breteler MM (2000) Vascular risk factors for alzheimer's disease: An epidemiologic perspective. Neurobiol Aging 21, 153-160. (Pubitemid 30387074)
85. de la Torre JC (2012) A turning point for alzheimer's disease? Biofactors 38, 778-783.
86. Austin BP, Nair VA, Meier TB, Xu G, Rowley HA, Carlsson CM, Johnson SC, Prabhakaran V (2011) Effects of hypoperfusion in alzheimer's disease. J Alzheimers Dis 26(Suppl 3), 123-133.
87. Glodzik L, Rusinek H, Brys M, Tsui WH, Switalski R, Mosconi L, Mistur R, Pirraglia E, de Santi S, Li Y, Goldowsky A, de Leon MJ (2011) Framingham cardiovascular risk profile correlates with impaired hippocampal and cortical vasoreactivity to hypercapnia. J Cereb Blood Flow Metab 31, 671-679.
88. Li J, Wang YJ, Zhang M, Xu ZQ, Gao CY, Fang CQ, Yan JC, Zhou HD (2011) Chongqing Ageing Study Group. Vascular risk factors promote conversion from mild cognitive impairment to alzheimer disease. Neurology 76, 1485-1491.
89. Solfrizzi V, Panza F, Colacicco AM, D'Introno A, Capurso C, Torres F, Grigoletto F, Maggi S, Del Parigi A, Reiman EM, Caselli RJ, Scafato E, Farchi G, Capurso A (2004) Italian Longitudinal Study on AgingWorking Group. Vascular risk factors, incidence of MCI, and rates of progression to dementia. Neurology 63, 1882-1891. (Pubitemid 39532385)
90. Panza F, D'Introno A, Colacicco AM (2006) Cognitive frailty: Predementia syndrome and vascular risk factors. Neurobiol Aging 27, 933-940. (Pubitemid 43732521)
91. Villeneuve S, Massoud F, Bocti C, Gauthier S, Belleville S (2011) The nature of episodic memory deficits in MCI with and without vascular burden. Neuropsychologia 49, 3027-3035.
92. Ohara T, Doi Y, Ninomiya T, Hirakawa Y, Hata J, Iwaki T, Kanba S, Kiyohara Y (2011) Glucose tolerance status and risk of dementia in the community: The hisayama study. Neurology 77, 1126-1134.
93. Hirao K, Ohnishi T, Hirata Y, Yamashita F, Mori T, MoriguchiY, Matsuda H, Nemoto K, Imabayashi E,Yamada M, Iwamoto T, Arima K, Asada T (2005) The prediction of rapid conversion to alzheimer's disease in mild cognitive impairment using regional cerebral blood flow SPECT. Neuroimage 28, 1014-1021. (Pubitemid 41713635)
94. Kume K, Hanyu H, Sato T, Hirao K, Shimizu S, Kanetaka H, Sakurai H, Iwamoto T (2011) Vascular risk factors are associated with faster decline of alzheimer disease: A longitudinal SPECT study. J Neurol 258, 1295-1303.
95. Solfrizzi V, Scafato E, Frisardi V, Seripa D, Logroscino G, Kehoe PG, Imbimbo BP, Baldereschi M, Crepaldi G, Di Carlo A, Galluzzo L, Gandin C, Inzitari D, Maggi S, Pilotto A, Panza F, Italian Longitudinal Study on Aging Working Group (2011) Angiotensin-converting enzyme inhibitors and incidence of mild cognitive impairment. AGE, doi: 10.1007/s11357-011-9360-z.
96. Lange-Asschenfeldt C, Kojda G (2008) alzheimer's disease, cerebrovascular dysfunction and the benefits of exercise: From vessels to neurons. Exp Gerontol 43, 499-504.
97. Tzourio C, Anderson C, ChapmanN(2003) Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Int Med 163, 1069-1075. (Pubitemid 36548935)
98. Duron E, HanonO(2010) Antihypertensive treatments, cognitive decline, and dementia. J Alzheimers Dis 20, 903-914.
99. Giles TD, Sander GE, Nossaman BD, Kadowitz PJ (2012) Impaired vasodilation in the pathogenesis of hypertension: Focus on nitric oxide, endothelial-Derived hyperpolarizing factors, and prostaglandins. J Clin Hypertens 14, 198-205.
100. Ghiadoni L, Taddei S, Virdis A (2012) Hypertension and endothelial dysfunction: Therapeutic approach. Curr Vasc Pharmacol 10, 42-60.
101. Virdis A, Taddei S (2011) How to evaluate microvascular organ damage in hypertension: Assessment of endothelial function. High Blood Press Cardiovasc Prev 18, 163-167.
102. Cheng J, Wu CC, Gotlinger KH, Zhang F, Falck JR, Narsimhaswamy D, Schwartzman ML (2010) 20-hydroxy-5,8,11,14-eicosatetraenoic acid mediates endothelial dysfunction via IkappaB kinase-Dependent endothelial nitric-oxide synthase uncoupling. J Pharmacol Exp Ther 332, 57-65.
103. Forstermann U (2010) Nitric oxide and oxidative stress in vascular disease. Pflugers Arch 459, 923-939.
104. Luo P, Yan M, Frohlich ED, Mehta JL, Hu C (2011) Novel concepts in the genesis of hypertension: Role of LOX-1. Cardiovasc Drugs Ther 25, 441-449.
105. TouyzRM(2005) Intracellular mechanisms involved in vascular remodelling of resistance arteries in hypertension: Role of angiotensin II. Exp Physiol 90, 449-455. (Pubitemid 40980144)
106. Boegehold MA (2007) Vascular remodeling and rarefaction in hypertension. In Comprehensive Hypertension. Lip GYH, Hall JE, Eds. Mosby/Elsevier, Philadelphia, pp. 157-166.
107. Bellien J, Iacob M, Remy-Jouet I, Lucas D, Monteil C, Gutierrez L, Vendeville C, Dreano Y, Mercier A, Thuillez C, Joannides R (2012) Epoxyeicosatrienoic acids contribute with altered nitric oxide and endothelin-1 pathways to conduit artery endothelial dysfunction in essential hypertension. Circulation 125, 1266-1275.
108. Singh M, Mensah GA, Bakris G (2010) Pathogenesis and clinical physiology of hypertension. Cardiol Clin 28, 545-559.
109. Chen JJ, Rosas HD, Salat D (2011) Age-Associated reductions in cerebral blood flow are independent from regional atrophy. Neuroimage 55, 468-478.
110. Grassi G, Mancia G (2007) Hyperadrenergic and labile hypertension. In Comprehensive Hypertension. Lip GYH, Hall JE, Eds. Mosby/Elsevier, Philadelphia, pp. 719-726.
111. Waldstein SR, Giggey PP, Thayer JF, ZondermanAB(2005) Nonlinear relations of blood pressure to cognitive function: The Baltimore Longitudinal Study of Aging. Hypertension 45, 374-379. (Pubitemid 40315806)
112. Elias MF, Wolf PA, D'Agostino RB, Cobb J, White LR (1993) Untreated blood pressure level is inversely related to cognitive functioning: The Framingham Study. Am J Epidemiol 138, 353-364. (Pubitemid 23289288)
113. Guo Z, Fratiglioni L, Winblad B, Viitanen M (1997) Blood pressure and performance on the Mini-Mental State Examination in the very old. Cross-Sectional and longitudinal data from the Kungsholmen Project. Am J Epidemiol 145, 1106-1113. (Pubitemid 27272940)
114. Yeung SE, Thornton WL (2011) Age-Related effects of blood pressure on everyday cognitive function in community-Dwelling women. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn 18, 733-755.
115. Jennings JR, Zanstra Y (2009) Is the brain the essential in hypertension? Neuroimage 47, 914-921.
116. Sir'o P, Moln'ar C, Katona E, Antek C, Koll'ar J, Settakis G, Fulesdi B (2009) Carotid intima-media thickness and cerebrovascular reactivity in long-Term type 1 diabetes mellitus. J Clin Ultrasound 37, 451-456.
117. Petrica L, Petrica M, Vlad A, Bob F, Gluhovschi C, Gluhovschi G, Jianu CD, Ursoniu S, Schiller A, Velciov S, Trandafirescu V, Bozdog G (2007) Cerebrovascular reactivity is impaired in patients with non-insulin-Dependent diabetes mellitus and microangiopathy. Wien Klin Wochenschr 119, 365-371. (Pubitemid 47087508)
118. Makimattila S, Malmberg-Ceder K, Hakkinen AM, Vuori K, Salonen O, Summanen P, Yki-Jarvinen H, Kaste M, Heikkinen S, Lundbom N, RoineRO(2004) Brain metabolic alterations in patients with type1 diabetes-hyperglycemiainduced injury. J Cereb Blood Flow Metab 24, 1393-1399. (Pubitemid 40019162)
119. Dandona P, Chaudhuri A, Aljada A (2004) Endothelial dysfunction and hypertension in diabetes mellitus. Med Clin North Am 88, 911-931. (Pubitemid 39090345)
120. Kalani M (2008) The importance of endothelin-1 for microvascular dysfunction in diabetes. Vasc Health Risk Manag 4, 1061-1068.
121. Busija DW, Miller AW, Katakam P, Simandle S, Erdös B (2004) Mechanisms of vascular dysfunctionin insulin resistance. Curr Opin Investig Drugs 5, 929-935.
122. Stewart R, Liolitsa D (1999) Type 2 diabetes mellitus, cognitive impairment and dementia. Diabet Med 16, 93-112.
123. Beeri MS, Silverman JM, Davis KL (2005) Type 2 diabetes is negatively associated with alzheimer's disease neuropathology. J Gerontol A Biol Sci Med Sci 60, 471-475. (Pubitemid 40712864)
124. Heitner J, DicksonD(1997) Diabetics do not have increased Alzheimer-Type pathology compared with age-matched control subjects A retrospective postmortem immunocytochemical and histofluorescent study. Neurology 49, 1306-1311. (Pubitemid 27495634)
125. Vigili de Kreutzenberg S, Tiengo A, Avogaro A (2009) Cerebrovascular disease in diabetes mellitus: The role of carotid intima-media thickness. Nutr Metab Cardiovasc Dis 19, 667-673.
126. Mudr'ikov'a T, Szabov'a E, Tk'ac I (2000) Carotid intimamedia thickness in relation to macrovascular disease in patients with type 2 diabetes mellitus.Wien KlinWochenschr 112, 887-891.
127. Claus JJ, Breteler MM, Hasan D, Krenning EP, Bots ML, Grobbee DE, Van Swieten JC, Van Harskamp F, Hofman A (1998) Regional cerebral blood flow and cerebrovascular risk factors in the elderly population. Neurobiol Aging 19, 57-64. (Pubitemid 28167796)
128. Wendell CR, Zonderman AB, Metter EJ, Najjar SS, Waldstein SR (2009) Carotid intimal medial thickness predicts cognitive decline among adults without clinical vascular disease. Stroke 40, 3180-3185.
129. Pereira FS, Yassuda MS, Oliveira AM, Forlenza OV (2008) Executive dysfunction correlates with impaired functional status in older adults with varying degrees of cognitive impairment. Int Psychogeriatr 20, 1104-1115.
130. Gomar JJ, Bobes-Bascaran MT, Conejero-Goldberg C, Davies P, Goldberg TE (2011) alzheimer's Disease Neuroimaging Initiative. Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to alzheimer disease in patients in the alzheimer's disease neuroimaging initiative. Arch Gen Psychiatry 68, 961-969.
131. Hofman A, Ott A, Breteler MM, Bots ML, Slooter AJ, van Harskamp F, van Duijn CN, Van Broeckhoven C, Grobbee DE (1997) Atherosclerosis, apolipoprotein E, and prevalence of dementia and alzheimer's disease in The rotterdam study. Lancet 349, 151-154. (Pubitemid 27039193)
132. Silvestrini M, Viticchi G, Falsetti L, Balucani C, Vernieri F, Cerqua R, Luzzi S, Bartolini M, Provinciali L (2011) The role of carotid atherosclerosis in alzheimer's disease progression. J Alzheimers Dis 25, 719-726.
133. Mathiesen EB,Waterloo K, Joakimsen O, Bakke SJ, Jacobsen EA, Bønaa KH (2004) Reduced neuropsychological test performance in asymptomatic carotid stenosis: The Tromsø Study. Neurology 62, 695-701. (Pubitemid 38298942)
134. Johnston SC, O'Meara ES, Manolio TA, Lefkowitz D, O'Leary DH, Goldstein S, CarlsonMC,FriedLP, Longstreth WT Jr (2004) Cognitive impairment and decline are associated with carotid artery disease in patients without clinically evident cerebrovascular disease. Ann Intern Med 140, 237-247.
135. Sander K, Bickel H, Förstl H, Etgen T, Briesenick C, Poppert H, Sander D (2010) Carotid- intima media thickness is independently associated with cognitive decline The INVADE study. Int J Geriatr Psychiatry 25, 389-394.
136. Silvestrini M, Paolino I, Vernieri F, Pedone C, Baruffaldi R, Gobbi B, Cagnetti C, Provinciali L, BartoliniM(2009) Cerebral hemodynamics and cognitive performance in patients with asymptomatic carotid stenosis. Neurology 72, 1062-1068.
137. Lal BK, Younes M, Cruz G, Kapadia I, Jamil Z, Pappas PJ (2011) Cognitive changes after surgery vs stenting for carotid artery stenosis. J Vasc Surg 54, 691-698.
138. Cantin S, Villien M, Moreaud O, Tropres I, Keignart S, Chipon E, Le Bas JF,Warnking J, KrainikA(2011) Impaired cerebral vasoreactivity to CO2 in alzheimer's disease using BOLD fMRI. Neuroimage 58, 579-587.
139. Napoli C (2002) Nitric oxide and atherosclerotic lesion progression: An overview. J Card Surg 17, 355-362. (Pubitemid 36071994)
140. de la Torre JC, Fortin T, Park GA, Butler KS, Kozlowski P, PappasBA, de Socarraz H, Saunders JK, RichardMT(1992) Chronic cerebrovascular insufficiency induces dementialike deficits in aged rats. Brain Res 582, 186-195.
141. de la Torre JC, Fortin T, Park GA, Pappas BA (1993) Brain blood flow restoration 'rescues' chronically damaged rat CA1 neurons. Brain Res 623, 6-15. (Pubitemid 23267383)
142. Huang Y, ZhangW, Lin L, Feng J, Chen F,WeiW, Zhao X, Guo W, Li J, Yin W, Li L (2010) Is endothelial dysfunction of cerebral small vessel responsible for white matter lesions after chronic cerebral hypoperfusion in rats? J Neurol Sci 299, 72-80.
143. Wang X, Xing A, Xu C, Cai Q, Liu H, Li L (2010) Cerebrovascular hypoperfusion induces spatial memory impairment, synaptic changes, and amyloid- oligomerization in rats. J Alzheimers Dis 21, 813-822.
144. Cechetti F, Pagnussat AS, Worm PV, Elsner VR, Ben J, da Costa MS,Mestriner R,Weis SN, Netto CA (2012) Chronic brain hypoperfusion causes early glial activation and neuronal death, and subsequent long-Term memory impairment. Brain Res Bull 87, 109-116.
145. Duan W, Chun-Qing Z, Zheng J, Gui L, Huang HQ, Chen KN(2011) Relief of carotid stenosis improves impaired cognition in a rat model of chronic cerebral hypoperfusion. Acta Neurobiol Exp (Wars) 71, 233-243.
146. Marshall RS, Festa JR, Cheung YK, Chen R, Pavol MA, Derdeyn CP, Clarke WR, Videen TO, Grubb RL, Adams HP, Powers WJ, Lazar RM (2012) Cerebral hemodynamics and cognitive impairment: Baseline data from the RECON trial. Neurology 78, 250-255.
147. Dai W, Lopez OL, Carmichael OT, Becker JT, Kuller LH, Gach HM (2009) Mild cognitive impairment and alzheimer disease: Patterns of altered cerebral blood flow atMR imaging. Radiology 250, 856-866.
148. Mineva PP,Manchev IC, Hadjiev DI (2002) Prevalence and outcome of asymptomatic carotid stenosis: A populationbased ultrasonographic study. Eur J Neurol 9, 383-388. (Pubitemid 35013894)
149. Purandare N, Voshaar RC, Morris J, Byrne JE, Wren J, Heller RF, McCollum CN, Burns A (2007) Asymptomatic spontaneous cerebral emboli predict cognitive and functional decline in dementia. Biol Psychiatry 62, 339-344. (Pubitemid 47444282)
150. Sillesen H, Schroeder T (1989) Haemodynamic evaluation of carotid artery disease. Clin Phys Physiol Meas 10(Suppl A), 15-22. (Pubitemid 19068147)
151. Sillesen H, Schroeder T, Buchardt Hansen HJ (1988) Haemodynamic evaluation of the cerebral circulation by periorbital Doppler examination and cerebral blood flow (CBF) measurement in carotid artery disease. Neurol Res 10, 57-60.
152. de la Torre JC (2010) Vascular risk factor detection and control may prevent alzheimer's disease. Ageing Res Rev 9, 218-225.
153. Komulainen P, Kivipelto M, LakkaTA, Hassinen M, Helkala EL, Patja K, Nissinen A, RauramaaR(2007) Carotid intimamedia thickness and cognitive function in elderly women: A population-Based study. Neuroepidemiology 28, 207-213. (Pubitemid 47573715)
154. Cobble M, Bale B (2010) Carotid intima-media thickness: Knowledge and application to everyday practice. Postgrad Med 122, 10-18.
155. Hodis HN, Mack WJ, LaBree L, Selzer RH, Liu CR, Liu CH, Azen SP (1998) The role of carotid arterial intimamedia thickness in predicting clinical coronary events. Ann Intern Med 128, 262-269. (Pubitemid 28090756)
156. Lakatta EG, Levy D (2003) Arterial and cardiac aging: Major shareholders in cardiovascular disease enterprises: Part II: The aging heart in health: Links to heart disease. Circulation 107, 346-354. (Pubitemid 36135235)
157. Haley AP, Forman DE, Poppas A, Hoth KF, Gunstad J, Jefferson AL, Paul RH, Ler AS, Sweet LH, Cohen RA (2007) Carotid artery intima-media thickness and cognition in cardiovascular disease. Int J Cardiol 121, 148-154. (Pubitemid 47385831)
158. Negi SI, Nambi V (2012) The role of carotid intimal thickness and plaque imaging in risk stratification for coronary heart disease. Curr Atheroscler Rep 14, 115-123.
159. Zhong W, Cruickshanks KJ, Huang GH, Klein BE, Klein R, Nieto FJ, Pankow JS, Schubert CR (2011) Carotid atherosclerosis and cognitive function in midlife: The Beaver Dam Offspring Study. Atherosclerosis 219, 330-333.
160. de la Torre JC (2009) Carotid artery ultrasound and echocardiography testing to lower the prevalence of alzheimer's disease. J Stroke Cerebrovasc Dis 18, 319-328.
161. Grammas P (2011) Vascular signaling abnormalities in alzheimer's disease. Cleve Clinic J Med 78(Suppl 1), S50-S53.
162. de la Torre JC, Aliev G (2005) Inhibition of vascular nitric oxide after